OSL oncosil medical ltd

Ann: Half Yearly Report and Accounts, page-83

  1. 2,588 Posts.
    lightbulb Created with Sketch. 257
    Whytee,

    Placebo, RCT trial, Control arm trial etc etc. No longer a relevant consideration given that BSI and the COC appear to have accepted the data, trial and protocols as presented by Oncosil, and evidenced by BSI’s Positive Status Report which was issued in October 2019.

    Cheers,

    GW
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
97.0¢
Change
-0.035(3.48%)
Mkt cap ! $13.79M
Open High Low Value Volume
$1.00 $1.01 97.0¢ $66.41K 66.80K

Buyers (Bids)

No. Vol. Price($)
2 3907 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 3000 1
View Market Depth
Last trade - 15.47pm 23/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.